ARCHIVES

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

MD Anderson President Ronald DePinho: “Some of the Feedback was Humbling”

March 29, 2013

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady wins RSNA Medal

January 12, 1990

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

NCI Begins PLCO Screening Trial

November 26, 1993

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

Cancergrams Cost $840 Year For All

December 2, 1977